Td Private Client Wealth LLC Neurocrine Biosciences Inc Transaction History
Td Private Client Wealth LLC
- $3.58 Trillion
- Q4 2024
A detailed history of Td Private Client Wealth LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Td Private Client Wealth LLC holds 79 shares of NBIX stock, worth $8,610. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79
Previous 79
-0.0%
Holding current value
$8,610
Previous $9.1 Million
18.48%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding NBIX
# of Institutions
655Shares Held
96.6MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.55 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.1 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$533 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$329 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$277 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.4B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...